Albion Financial Group UT Sells 125,000 Shares of KORU Medical Systems, Inc. (NASDAQ:KRMD)

Albion Financial Group UT lowered its position in shares of KORU Medical Systems, Inc. (NASDAQ:KRMD - Free Report) by 22.1% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 441,374 shares of the company's stock after selling 125,000 shares during the quarter. Albion Financial Group UT owned approximately 0.96% of KORU Medical Systems worth $1,121,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in KRMD. Topline Capital Management LLC acquired a new position in shares of KORU Medical Systems during the fourth quarter worth about $16,660,000. First Light Asset Management LLC raised its stake in KORU Medical Systems by 5.7% in the fourth quarter. First Light Asset Management LLC now owns 5,915,434 shares of the company's stock valued at $22,774,000 after buying an additional 316,509 shares during the period. 683 Capital Management LLC bought a new stake in KORU Medical Systems in the fourth quarter valued at approximately $340,000. Russell Investments Group Ltd. raised its stake in KORU Medical Systems by 41,806.9% in the fourth quarter. Russell Investments Group Ltd. now owns 67,051 shares of the company's stock valued at $258,000 after buying an additional 66,891 shares during the period. Finally, Schonfeld Strategic Advisors LLC bought a new stake in KORU Medical Systems in the fourth quarter valued at approximately $143,000. Institutional investors own 58.60% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on KRMD shares. Piper Sandler lowered their target price on KORU Medical Systems from $4.50 to $3.50 and set a "neutral" rating on the stock in a research note on Thursday, May 8th. B. Riley raised KORU Medical Systems to a "strong-buy" rating in a report on Thursday, March 13th. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Buy" and an average target price of $4.50.

KORU Medical Systems Price Performance

Shares of NASDAQ KRMD traded down $0.11 during mid-day trading on Wednesday, hitting $3.58. 68,442 shares of the stock traded hands, compared to its average volume of 142,144. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.44 and a quick ratio of 2.02. KORU Medical Systems, Inc. has a twelve month low of $1.86 and a twelve month high of $5.05. The company has a market cap of $164.95 million, a PE ratio of -32.50 and a beta of 0.52. The firm has a 50 day simple moving average of $3.02 and a two-hundred day simple moving average of $3.33.

KORU Medical Systems (NASDAQ:KRMD - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.01). The firm had revenue of $9.64 million for the quarter, compared to analyst estimates of $8.86 million. KORU Medical Systems had a negative net margin of 15.09% and a negative return on equity of 30.43%. As a group, equities research analysts forecast that KORU Medical Systems, Inc. will post -0.13 EPS for the current fiscal year.

KORU Medical Systems Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.